Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications.
Item(s) added to cart.
For laboratory use only. This product is intended for animal research only and not for use in humans.
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
OsteoSense® 800 is a targeted fluorescent in vivo bisphosphonate imaging agent. OsteoSense 800 images areas of microcalcifications and bone remodeling and enables imaging of bone growth and resorption. OsteoSense 800 fluorescent imaging agent at a wavelenth at 800 nm, can be used to measure the effects of therapeutic stimulation of bone growth. This agent can also be used to characterize bone remodeling associated with animal models of arthritis. OsteoSense 800 enables in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.
|Fluorescent Agent Type||Targeted|
|Optical Imaging Classification||Fluorescence Imaging|
|Product Brand Name||OsteoSense|
|Quantity in a Package Amount||1.0 Units|
|Therapeutic Area||Atherosclerosis, Arthritis, Oncology/Cancer|
|Unit Size||1 Vial (10 doses)|
|Wave Length||800 nm|
Imaging of Cathepsin K activity in rodent models of bone turnover and soft tissue calcification
Protocol for OsteoSense 800 targeted fluorescent in vivo imaging agent
OsteoSense® 800 is a fluorescent in vivo diphosphonate imaging agent. OsteoSense 800 images areas of microcalcification and bone remodeling and enables imaging of bone growth and resorption.